WJ
Wang Julia Aijun
Chief Financial Officer
OtherF
€868,182
▼ Sales (12 ops.)
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Wang Julia Aijun, Chief Financial Officer. Officer active across 2 companies, notably BeiGene, Ltd.. In total, 17 filings have been logged. Split: 0 buy · 12 sells. Total volume traded: €868k. History available since 1 July 2021. The latest transaction was disclosed on 1 July 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations17 total
893 sharesCommon StockSEC:0001127602-25-003711:0
472 shares@ US$143.89557.3% of flowAmerican Depositary SharesSEC:0001651308-24-000080:0
899 shares@ US$155.6615.0% of flowAmerican Depositary SharesSEC:0001651308-24-000079:0
154 shares@ US$158.23682.6% of flowAmerican Depositary SharesSEC:0001651308-24-000074:0
136,240 shares0Ordinary SharesSEC:0001651308-24-000056:0
397 shares@ US$167.087.0% of flowAmerican Depositary SharesSEC:0001651308-24-000016:0
472 shares@ US$179.54958.9% of flowAmerican Depositary SharesSEC:0001651308-23-000104:0
840 shares@ US$182.8516.1% of flowAmerican Depositary SharesSEC:0001651308-23-000102:0
107,770 shares0Ordinary SharesSEC:0001651308-23-000091:0
343 shares@ US$240.20969.0% of flowAmerican Depositary SharesSEC:0001651308-23-000037:0
317 shares@ US$158.505.5% of flowAmerican Depositary SharesSEC:0001651308-22-000125:0
295 shares@ US$158.505.1% of flowAmerican Depositary SharesSEC:0001651308-22-000119:0
104,377 shares0Ordinary SharesSEC:0001651308-22-000112:0
161 shares@ US$136.63930.0001% mcap10.3% of flowAmerican Depositary SharesSEC:0001651308-22-000084:0
61,750 shares0Ordinary SharesSEC:0001651308-22-000035:0
308 shares@ US$349.06390.0003% mcap44.8% of flowAmerican Depositary SharesSEC:0001651308-21-000147:0
308 shares@ US$349.063910.5% of flowAmerican Depositary SharesSEC:0001651308-21-000147
About Wang Julia Aijun
Julia Aijun Wang is the Chief Financial Officer at BeiGene, Ltd. She is responsible for the financial management of the company, including budgeting, risk management, and financial analysis. Her expertise contributes to strategic decision-making that promotes the growth and profitability of BeiGene.